# Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/utility-of-a-novel-serum-tumor-biomarker-he4-in-patients-with-endometrioid/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Richard G. Moore,Amy Brown,Michael Craig Miller,Donna Badgwell,Zhen Lü,W. Jeffrey Allard,C.O. Granai,Robert C. Bast,Karen Lu |
| Citations | 232 |
| DOI | 10.1016/j.ygyno.2008.04.002 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1992217756 |
| PMID | 18495222 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Richard G. Moore](https://scholariq.org/researchers/richard-g-moore/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.